On 27 September 2022 the second edition of Leiden Drug Development Conference (LDDC) will be organised by LUMC, Leiden University, Janssen, Galapagos and TNO.

Which technologies and innovations will radically change the research and development of medicines in the future? And how can we make medicines and vaccines, while the conditions within which we do this, are deteriorating? We want to discuss the complexity of the development, production and distribution of medicines.

Computational science, prevention, federated data networks and anti-infectives. The future of drug development is the main topic on the agenda. During this conference leading scientists and professionals will tell you the latest  in their research field. And our keynote speaker Paul Stoffels (CEO Galapagos) will give his view on the topic.

The aim is to actively connect business and science, discover how we can reinforce each other, and work together on the future of life sciences and health.

LDDC 2022 invites scientists and professionals, from universities, knowledge institutes and industry with an interest in drug discovery, development and production, to register.

Location: ECC Leiden, Haagse Schouwweg 10, Leiden

Time 09.00-17.00 hrs

Ticket: Free! Register via the webiste: www.hyphenprojects.nl/lddc/ 

For more information: www.hyphenprojects.nl/lddc/